UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000051707 |
|---|---|
| Receipt number | R000059011 |
| Scientific Title | Online Survey Analysis of Healthcare Providers' Experiences and Responses to Complementary and Alternative Medicine Consultations in Oncology |
| Date of disclosure of the study information | 2023/08/01 |
| Last modified on | 2023/07/25 12:29:41 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Healthcare Experience and Response to Oncological Complementary and Alternative Medicine
Acronym
HERO-CAM study
Scientific Title
Online Survey Analysis of Healthcare Providers' Experiences and Responses to Complementary and Alternative Medicine Consultations in Oncology
Scientific Title:Acronym
HERO-CAM study
Region
| Japan |
Condition
Condition
Healthcare professionals who deal with cancer.
Classification by specialty
| Medicine in general | Gastroenterology | Hepato-biliary-pancreatic medicine |
| Pneumology | Endocrinology and Metabolism | Hematology and clinical oncology |
| Nephrology | Geriatrics | Surgery in general |
| Gastrointestinal surgery | Hepato-biliary-pancreatic surgery | Chest surgery |
| Endocrine surgery | Breast surgery | Obstetrics and Gynecology |
| Pediatrics | Ophthalmology | Dermatology |
| Psychiatry | Oto-rhino-laryngology | Orthopedics |
| Urology | Radiology | Oral surgery |
| Neurosurgery | Plastic surgery | Rehabilitation medicine |
| Nursing | Adult | Child |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The aim of this study is to collect information about the consultations received by healthcare professionals from cancer patients regarding complementary and alternative therapies and to clarify the current situation by examining how these professionals respond to such inquiries.
Basic objectives2
Others
Basic objectives -Others
This study will investigate the following research questions:
1. What types of consultations regarding complementary and alternative therapies are healthcare professionals receiving from cancer patients?
2. How are healthcare professionals responding to these consultations?
3. What knowledge do healthcare professionals have about complementary and alternative therapies, and how are they handling them?
Trial characteristics_1
Exploratory
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
The proportion of healthcare professionals who have received consultations about complementary and alternative therapies from cancer patients.
Key secondary outcomes
1. The content and proportion of consultations received regarding complementary and alternative therapies, folk remedies, health foods, and supplements.
2. The correlation between the responses after the consultation and the participants' background factors (age, gender, professional classification, years of experience, and education).
3. The correlation between how the participants felt when they received the consultation and their background factors (age, gender, professional classification, years of experience, and education).
4. The correlation between the subsequent treatment policy and the participants' background factors (age, gender, professional classification, years of experience, and education).
5. The correlation between the participants' views on complementary and alternative therapies or folk remedies and their background factors (age, gender, professional classification, years of experience, and education).
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Being a healthcare professional.
2) Directly or indirectly involved with cancer patients.
Key exclusion criteria
1) Multiple survey entries by the same person (excluded systematically).
2) Not currently working as a healthcare professional.
3) Not involved in cancer care.
Target sample size
2500
Research contact person
Name of lead principal investigator
| 1st name | Michio |
| Middle name | |
| Last name | Nakamura |
Organization
Sapporo City General Hospital
Division name
Department of Gastroenterology
Zip code
060-8604
Address
1-1, Kita 11-jo Nishi 13-chome, Chuo-ku, Sapporo, JAPAN
TEL
81-11-726-2211
michio.nakamura@doc.city.sapporo.jp
Public contact
Name of contact person
| 1st name | Michio |
| Middle name | |
| Last name | Nakamura |
Organization
Sapporo City General Hospital
Division name
Department of Gastroenterology
Zip code
060-8604
Address
1-1, Kita 11-jo Nishi 13-chome, Chuo-ku, Sapporo, JAPAN
TEL
81-11-726-2211
Homepage URL
michio.nakamura@doc.city.sapporo.jp
Sponsor or person
Institute
Non-Profit Organization: Hokkaido Association of Supportive Care in Cancer Patients (HASCAP)
Institute
Department
Personal name
Funding Source
Organization
Non-Profit Organization: Hokkaido Association of Supportive Care in Cancer Patients (HASCAP)
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Sapporo City General Hospital Ethics Committee
Address
1-1, Kita 11-jo Nishi 13-chome, Chuo-ku, Sapporo, JAPAN
Tel
81-11-726-2211
ho.shomu@city.sapporo.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
ＮＰＯ法人北海道がんサポーティブケア協会（北海道）
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 08 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2023 | Year | 07 | Month | 13 | Day |
Date of IRB
| 2023 | Year | 07 | Month | 20 | Day |
Anticipated trial start date
| 2023 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2023 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
| 2023 | Year | 09 | Month | 30 | Day |
Date trial data considered complete
| 2023 | Year | 12 | Month | 31 | Day |
Date analysis concluded
| 2023 | Year | 12 | Month | 31 | Day |
Other
Other related information
Currently preparing for the start of the trial.
Management information
Registered date
| 2023 | Year | 07 | Month | 25 | Day |
Last modified on
| 2023 | Year | 07 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059011
